EGFR mutation testing practices within the Asia pacific region: Results of a multicenter diagnostic survey

Journal of Thoracic Oncology

Volumn 10, Issue 3, 2015, Pages 438-445

  Yatabe, Yasushi ^a   Kerr, Keith M ^b   Utomo, Ahmad ^c   Rajadurai, Pathmanathan ^d   Tran, Van Khanh ^e   Du, Xiang ^f   Chou, Teh Ying ^g   Enriquez, Ma Luisa D ^h,i   Lee, Geon Kook ^j   Iqbal, Jabed ^k   Shuangshoti, Shanop ^l   Chung, Jin Haeng ^m   Hagiwara, Koichi ⁿ   Liang, Zhiyong ^o   Normanno, Nicola ^p   Park, Keunchil ^q   Toyooka, Shinichi ^r   Tsai, Chun Ming ^g   Waring, Paul ^s   Zhang, Li ^t   Mccormack, Rose ^u   Ratcliffe, Marianne ^u   Itoh, Yohji ^u   Sugeno, Masatoshi ^u   Mok, Tony ^v   more..

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c Stem Cell and Cancer Institute   (Indonesia)

^d MONASH UNIVERSITY MALAYSIA   (Malaysia)

^e HANOI MEDICAL UNIVERSITY   (Viet Nam)

^f FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^g TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^h ST LUKE S MEDICAL CENTER   (Philippines)

ⁱ DE LA SALLE UNIVERSITY   (Philippines)

^j National Cancer Center   (South Korea)

^k SINGAPORE GENERAL HOSPITAL   (Singapore)

^l KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^m Seoul National University Bundang Hospital   (South Korea)

ⁿ SAITAMA MEDICAL UNIVERSITY   (Japan)

^o PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^p NATIONAL CANCER INSTITUTE   (Italy)

^q Sungkyunkwan University   (South Korea)

^r OKAYAMA UNIVERSITY   (Japan)

^s UNIVERSITY OF MELBOURNE   (Australia)

^t SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^u ASTRAZENECA   (United Kingdom)

^v CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

more..

Author keywords

EGFR mutation; Multicenter; Non small cell lung cancer; Survey; Testing

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; DIAGNOSTIC KIT; DNA; EGFR PROTEIN, HUMAN;

ARTICLE; ASIA; BIOPSY; CANCER PATIENT; CYTOLOGY; DNA SEQUENCE; FEMALE; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ADENOCARCINOMA; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIAL; DIAGNOSTIC KIT; DNA MUTATIONAL ANALYSIS; FACTUAL DATABASE; FOLLOW UP; GENETICS; LUNG NEOPLASMS; MUTATION; PACIFIC ISLANDS; POLYMERASE CHAIN REACTION; PROCEDURES; PROGNOSIS;

ADENOCARCINOMA; ASIA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DATABASES, FACTUAL; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MUTATION; NEOPLASM STAGING; PACIFIC ISLANDS; POLYMERASE CHAIN REACTION; PROGNOSIS; REAGENT KITS, DIAGNOSTIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES;

EID: 84931571793     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000422     Document Type: Article

References (19)

1. Dearden S, Stevens J, Wu YL, Blowers D, Mutation incidence and coincidence in non small-cell lung cancer: Meta-Analyses by ethnicity and histology (mutMap). Ann Oncol 2013 24 2371 2376
2. GLOBOCAN (IARC) 2012. Lung cancer fact sheet. http://globocan.iarc.fr/Pages/fact-sheets-cancer.aspx. Accessed March 17, 2014
3. Ding L, Getz G, Wheeler DA, Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008 455 1069 1075
4. Pao W, Girard N, New driver mutations in non-small-cell lung cancer. Lancet Oncol 2011 12 175 180
5. Mok TS, Wu YL, Thongprasert S, Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009 361 947 957
6. Mitsudomi T, Yatabe Y, Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer. Cancer Sci 2007 98 1817 1824
7. Lee JS, Park K, Kim SW, A randomized phase III study of gefitinib (IRESSA) versus standard chemotherapy (gemcitabine plus cisplatin) as a first-line treatment for never smokers with advanced or metastatic adenocarcinoma of the lung. J Thorac Oncol 2009 4 S283 S284
8. Maemondo M, Inoue A, Kobayashi K, North-East Japan Study Group Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 2010 362 2380 2388
9. Mitsudomi T, Morita S, Yatabe Y, West Japan Oncology Group Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): An open label, randomised phase 3 trial. Lancet Oncol 2010 11 121 128
10. Rosell R, Carcereny E, Gervais R, Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia Toracica Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): A multicentre, open-label, randomised phase 3 trial. Lancet Oncol 2012 13 239 246
11. Zhou C, Wu YL, Chen G, Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): A multicentre, open-label, randomised, phase 3 study. Lancet Oncol 2011 12 735 742
12. Marchetti A, Normanno N, Pinto C, AIOM-SIAPEC-IAP; Italian Association of Medical Oncology; Italian Society of Anatomic Pathology and Diagnostic Cytopathology Recommendations for mutational analysis of EGFR in lung carcinoma. Pathologica 2010 102 119 126
13. Pirker R, Herth FJ, Kerr KM, European EGFR Workshop Group Consensus for EGFR mutation testing in non-small cell lung cancer: Results from a European workshop. J Thorac Oncol 2010 5 1706 1713
14. Xue C, Hu Z, Jiang W, National survey of the medical treatment status for non-small cell lung cancer (NSCLC) in China. Lung Cancer 2012 77 371 375
15. Tokumo M, Toyooka S, Kiura K, The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers. Clin Cancer Res 2005 11 1167 1173
16. Yoshida K, Yatabe Y, Park JY, Prospective validation for prediction of gefitinib sensitivity by epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer. J Thorac Oncol 2007 2 22 28
17. Ellison G, Zhu G, Moulis A, EGFR mutation testing in lung cancer: A review of available methods and their use for analysis of tumour tissue and cytology samples. J Clin Pathol 2013 66 79 89
18. Lindeman NI, Cagle PT, Beasley MB, Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. Arch Pathol Lab Med 2013 137 828 860
19. Goto K, Satouchi M, Ishii G, An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting. Ann Oncol 2012 23 2914 2919